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Objectives This study sought to analyze the presentation, surgical procedures, and outcomes in patients 50 years of age
with Ebstein anomaly (EA).
Background Data on management and surgical outcomes in older patients with EA are limited.
Methods Operative and clinical data from patients with EA 50 years of age undergoing cardiac surgery at our center
between October 1980 and January 2010 were analyzed.
Results During the study period, 89 procedures were performed in 81 patients with EA (63% women; mean [range] age
59 [50 to 79] years). Pre-operative symptoms included palpitations (n  69), edema (n  30), and previous
stroke/transient ischemic attack (n  21). Seventy-six patients (85%) had functional class III or IV symptoms,
and 13 (16%) had previous cardiac surgery. Tricuspid valve surgery was necessary in 87 of the 89 procedures
(98%): replacement in 65 (73%) and repair in 22 (25%). Three early deaths occurred (4%). On long-term
follow-up (available in 73 of 78 early survivors), 63 patients (89%) had improved functional class and 13 pa-
tients died (19%). The 20-year survival was 65% versus 74% for age- and sex-matched controls (p  0.001).
The best predictors of late death were lack of post-operative improvement and older age at surgery.
Conclusions Although cardiac surgery in patients with EA 50 years of age was often complex, early mortality was low (4%)
when surgery was performed at an experienced center. Long-term survival was good, although less than
expected. These data suggested that surgery in older patients with EA may have to be performed
earlier. (J Am Coll Cardiol 2012;59:2101–6) © 2012 by the American College of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2012.03.020r
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aEbstein anomaly (EA), a rare congenital heart malforma-
tion, occurs in approximately 1 to 5 per 200,000 live births
(1). EA encompasses a wide anatomic spectrum of abnor-
malities of the tricuspid valve (TV) leaflets and right
ventricle (RV), including atrialization due to apical displace-
ment of the tricuspid annulus. Common associated anom-
alies include atrial septal defect (ASD) and patent foramen
ovale, occurring in 90% of patients, and ventricular
re-excitation in approximately 15% of cases (2). Many
atients with EA survive and require repair in adulthood
3). Age at clinical presentation varies considerably by
natomic severity and by other associated heart diseases.
linical symptoms are age dependent and include cyanosis,
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2012, accepted March 6, 2012.ight-sided heart failure, arrhythmias, decreased exercise
olerance, fatigue, sudden cardiac death, and paradoxical
mboli (4). Optimal timing of intervention is often difficult
nd must be individualized (3,5–11).
Few data have been published on the operative outcomes
f patients with EA who are 50 years of age at the time of
urgery (11,12). Therefore, we sought to analyze clinical
resentation, surgical interventions, and outcomes of all
dults with EA at our institution who underwent operative
epair at 50 years of age.
ethods
e retrospectively searched our database for patients 50
ears of age who underwent operations for EA at Mayo
linic (Rochester, Minnesota) between October 1980 and
anuary 2010. Before 1980, no patients with EA in this age
roup had TV operations. The diagnosis of EA was based
n echocardiography in all patients. Inclusion criteria were
trioventricular and ventriculoarterial concordance and 2
entricles; we excluded patients with pulmonary atresia and
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ties. The indications for surgery in
patients with EA included dys-
pnea, heart failure, tachyarrhyth-
mias not amenable to another
therapy, ASD, progressive cardio-
megaly, and other associated lesions.
The Mayo Clinic Institutional Re-
view Board approved this study. All
patients gave informed consent to
participate according to the guide-
lines of our ethical committee.
Operative technique. Operative management of EA in-
cluded: 1) pre-operative electrophysiological mapping for
localization and ablation of accessory conduction pathways
in patients with ventricular pre-excitation; 2) closure of an
interatrial communication, if present; 3) elimination of
previously placed shunts and repair of associated anomalies;
4) performance of any indicated antiarrhythmia procedures;
5) selective plication of the atrialized RV; 6) reconstruction
of the TV or TV replacement; and 7) excision of redundant
right atrial wall (2,3,13). Our TV repair techniques for EA
have evolved during the past 30 years (14).
Tricuspid valve surgery. Various modifications of the TV
repair procedure were used to address the numerous variants
of EA (3,13); in general, the procedures consisted of a
monocusp repair at the level of the functional annulus.
Plication was reserved for atrialized RV that was thinned
and dyskinetic.
When TV replacement was performed, anterior leaflet
tissue toward the RV outflow tract was excised to avoid
potential RV outflow tract obstruction after bioprosthetic
valve replacement (15). The position of the os of the coronary
sinus relative to the prosthesis (draining into the right atrium
or RV) was determined by the proximity of the coronary
sinus to the conduction tissue. When there was sufficient
distance between the 2 structures, the bioprosthesis was
positioned so that the coronary sinus drained into the right
atrium (i.e., the prosthesis went between the conduction
tissue and the coronary sinus). When the 2 structures were
close together, the prosthesis was positioned to the atrial
side of both to avoid heart block. In this situation, the
coronary sinus drained into the RV. Injury to the right
coronary artery was avoided by deviating the suture line
cephalad to the true TV annulus anteriorly and posterolat-
erally. The struts of the bioprosthetic valve were oriented so
that they straddled the membranous septum and conduction
tissue.
Antiarrhythmia surgery. In the earlier years of surgery,
intraoperative electrophysiological mapping for localization
and surgical division or cryoablation of the pathways were
performed in patients with accessory conduction pathways.
In the current era, pre-operative electrophysiological map-
ping and percutaneous ablation of accessory conduction
pathways is performed. Paroxysmal and persistent atrial
Abbreviations
and Acronyms
ASD  atrial septal defect
EA  Ebstein anomaly
LV  left ventricular
LVEF  left ventricular
ejection fraction
RV  right
ventricle/ventricular
TV  tricuspid valvefibrillation are treated with a modified cut-and-sew Coxmaze III procedure. In the presence of pre-operative atrial
flutter, the right atrial isthmus is cryoablated as well. In the
latter part of this series, cryoablation was applied from the
amputated right atrial appendage to the TV annulus to
decrease the possibility of damaging the arterial blood
supply to the sinoatrial node. We currently prefer cryoab-
lation to electrocautery at our center.
Statistical analysis. Demographic and other patient-
related data were obtained from medical records. Follow-up
information was obtained from clinic visits, correspondence
from local physicians, mailed questionnaires, and Social
Security Death Index (in all patients). Data are expressed as
mean  SD or number of patients (percentage). p  0.05
was considered statistically significant. Early operative mor-
tality was defined as death at any time during the index
hospitalization or within 30 days of operation. Survival was
estimated by using the Kaplan-Meier method and was
compared with an age- and sex-matched population using
the 1-sample log-rank test. Within the population of
operative survivors, variables associated with survival were
evaluated using Cox proportional hazards regression meth-
ods, and results are given as hazard ratios with 95%
confidence intervals.
Results
We identified 81 patients (10 patients before 1990) who
underwent 89 procedures for EA during the study period (1
patient had 3 operations, and 6 patients had 2 operations);
the average age at operation was 59 years (range 50 to 79
years). The clinical characteristics of the patients are shown
in Table 1. Average age at EA diagnosis was 43 years; 11
patients were 60 years of age at the time of diagnosis.
Most patients were markedly symptomatic: 85% were in
functional class III or IV at surgery. The most common
symptoms included dyspnea, palpitations, cyanosis, and
Clinical CharacteristicsTable 1 Clinical Characteristics
Patient characteristics (n  81)
Age at diagnosis, yrs 43 19
Women 51 (63)
Pre-procedural characteristics (n  89)
Patient age at surgery, yrs 59 8
New York Heart Association functional class
I/II 13 (15)
III/IV 76 (85)
Dyspnea 74 (83)
Palpitations 69 (78)
Edema 30 (34)
Cyanosis 21 (24)
Stroke/TIA 21 (24)
Dizziness 16 (18)
Right-sided heart failure 13 (15)
Syncope 7 (8)
Clubbing 6 (7)Values are mean  SD or n (%).
TIA  transient ischemic attack.
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pregnancies had of 1.7  1.2 children. The hemoglobin
value was 14.9  2.0 g/dl (range 10.8 to 19.7 g/dl).
Pre-operative left ventricular ejection fraction (LVEF) was
57% (11%) and was 50% in 23 patients (26%). A previous
stroke or transient ischemic attack had occurred in 21
patients (24%).
Prior cardiac surgery had been performed in 13 patients
(16%) 7 to 40 years previously. Prior operations included
ASD closure in 10 patients, TV repair in 2 patients, and TV
replacement in 2 patients.
Most patients were in sinus rhythm pre-operatively.
Paroxysmal or persistent atrial fibrillation was present in 19
patients (21%) and pre-excitation in 7 patients (8%). Four
patients had pacemakers, and 1 patient had an automatic
internal cardiac defibrillator. Moderate or severe mitral
regurgitation was present in 9 patients (10%). Cardiovascu-
lar risk factors included arterial hypertension in 29 patients
(33%), hyperlipidemia in 29 patients (33%), smoking his-
tory in 18 patients (20%), and diabetes mellitus in 4 patients
(4%). Of 75 patients (84%) who underwent coronary angiog-
raphy, coronary artery disease was found in 15 patients (20%).
Surgical procedures performed are shown in Table 2, with
prosthetic TV types shown in Table 3. Additionally,
pacemaker-lead thrombus was removed from 3 patients at
operation. One patient each had left atrial appendage ligation,
excision of a blood cyst from the TV, and resection of a left
ventricular (LV) aneurysm due to myocardial infarction. The
cardiopulmonary bypass time was 112  49 min (range 39 to
42 min), and mean cross-clamp time was 50 (29) min.
Two patients had a bidirectional cavopulmonary shunt as
n adjunct to TV replacement. A 57-year-old woman with
everely reduced RV function and mildly reduced LVEF
Surgical Procedures Performed (N  89)Table 2 Surgical Procedures Performed (N  89)
Procedure Type No. of Procedures (%)
Tricuspid valve operation
Repair 22 (25)
Replacement 65 (73)
None 2 (2)
ASD/PFO closure 58 (65)
Right reduction atrioplasty 41 (46)
Anterior right pericardectomy 18 (20)
Plication of atrialized RV 12 (13)
Right-sided maze procedure 18 (20)
Ablation of accessory pathway 9 (10)
CABG 9 (10)
Mitral valve surgery 6 (7)
Repair 4 (5)
Replacement 2 (2)
Bidirectional Glenn operation 2 (2)
Aortic root surgery 2 (2)
Repair of PS 1 (1)
Permanent pacing 1 (1)h
ASD  atrial septal defect; CABG  coronary artery bypass grafting; PFO  patent foramen ovale;
PS  pulmonary stenosis; RV  right ventricle.43%) remained severely symptomatic post-operatively dur-
ng a 33-month follow-up. The other patient was a 56-year-
ld man with severely reduced RV function and mildly
educed LVEF (48%). His symptoms improved during a
8-month follow-up. Neither patient had symptoms attrib-
table to increased superior vena cava pressure.
Three patients (4%) died early, all with operations before
995. A 72-year-old man died during TV repair, suture
losure of an ASD, coronary artery bypass surgery, and
esection of an LV aneurysm. A 71-year-old man died early
ost-operatively of ventricular arrhythmias after undergoing
V replacement with a 33-mm mechanical St. Jude pros-
hesis. A 65-year-old man with diabetes mellitus died on
ost-operative day 4 of a myocardial infarction and pulmo-
ary embolism.
ong-term follow-up and survival. Follow-up was avail-
ble for 73 of 78 survivors (94%); median follow-up was 84
onths (range 2 to 404 months). Follow-up was confirmed
y clinical evaluation in 33 patients, death notice in 12
atients, research questionnaire in 9 patients, outside phy-
ician report in 11 patients, or another contact in 8 patients.
For the 71 patients with clinical follow-up, improvement
n functional class occurred in 63 patients (89%). Post-
peratively, only 8 patients remained in functional class III
r IV (11%). Reoperation was necessary in 8 patients (7
erformed at our center). Reasons for reoperation (1
eason possible) included TV replacement for recurrent
ricuspid regurgitation (n  3), TV replacement for pros-
hetic dysfunction (n  4), TV re-repair for recurrent
ricuspid regurgitation (n  1), aortic valve replacement for
ortic stenosis (n  1), and mitral valve replacement for
itral regurgitation (n  1). Freedom from reoperation is
hown in Figure 1.
Of the 78 operative survivors, 13 died during follow-up
17%). Significant predictors of death by univariate analysis
ere lack of post-operative improvement (p  0.001), older
ge at surgery (p 0.007), pre-operative LVEF50% (p
.02), diabetes mellitus (p  0.02), and pre-operative
Types of TV ProsthesesUsed f r Replac ment (n  65)Table 3 Ty es of TV ProsthesesUsed for TV Replacement (n  65)
Mechanical Starr-Edwards ball-cage prosthesis, model* 7 (11)
4M 1
5M 6
Mechanical bileaflet prosthesis, size (mm) 13 (20)
31 5
33 8
Porcine BPV, size (mm) 45 (69)
25 1
29 1
31 2
33 8
35 33
Values are n (%). *Used before 1993.
BPV  bioprosthetic TV prosthesis; TV  tricuspid valve.istory of heart failure (p  0.01) (Table 4). Each of these
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however, no other predictors were significant after adjust-
ment for lack of post-operative improvement. Observed
long-term survival was lower than expected (p  0.001)
(Fig. 2). Actuarial 10-year survival was 71% vs. 88%
expected, and actuarial 20-year survival was 65% vs 74%
expected for an age- and sex-matched population.
Discussion
In our patients with EA undergoing surgery after age 50
years, early mortality was 4%; post-operative improvement
was noted in most patients. Long-term survival was accept-
able, although less than expected in an age- and sex-
matched population. This study suggested that cardiac
repair should be considered in patients with EA who are
older and have symptoms or advanced heart disease.
Clinical presentation. In this age group, a high percentage
of patients underwent operation because they were symp-
tomatic—89% were in New York Heart Association func-
tional class III or IV. Palpitations, edema, cyanosis, and a
history suggestive of paradoxical emboli were common and
most likely caused by advanced right-sided heart disease and
high right atrial pressures.
Figure 1 Kaplan-Meier Curve
Showing Freedom From Reoperation
Freedom from tricuspid valve repair or replacement in the 81 study patients.
Univariate Predictors of Death During Follow-upTable 4 Univariate Predictors of Death During Follow-up
Parameter HR (95% CI) p Value
No post-operative improvement 10.0 (3.01–33.4) 0.001
Pre-operative history of heart failure 4.42 (1.42–13.7) 0.01
Pre-operative LVEF 50% 3.59 (1.20–10.7) 0.02
Diabetes mellitus 6.76 (1.43–31.9) 0.02
Pulmonary hypertension 1.21 (0.36–4.08) 0.75
History of atrial fibrillation 0.95 (0.26–3.46) 0.94
Tricuspid valve replacement 1.63 (0.44–5.99) 0.46
Male 1.96 (0.65–5.89) 0.23
Age at surgery, per 10 yrs 2.53 (1.28–5.00) 0.007CI  confidence interval; HR  hazard ratio; LVEF  left ventricular ejection fraction.Tricuspid valve replacement. Because the myocardium in
EA is myopathic, it is important to eliminate most of the
tricuspid regurgitation so that RV remodeling can be
optimized. Although we generally prefer TV repair for
patients with EA, we have a lower threshold to proceed with
TV replacement in older patients, particularly if severe RV
or tricuspid annular enlargement or pulmonary hypertension
is present because these findings have been correlated with
poor TV repair durability. In our experience, TV replace-
ment provides the best outcome in older patients with EA
and has been performed with low early mortality and
excellent durability, comparable to our results in 539 pa-
tients with EA undergoing surgery at a median age of 24
years (3). TV replacement was performed in 65 of 89
operations (73%) in this series.
Our reported experience notes that valve repair and
replacement have similar freedoms from reoperation for
recurrent TV problems (15). In the current series, 45 of 65
patients (69%) who had TV replacement received a biopros-
thesis. Porcine bioprosthetic TVs are preferred to bovine
pericardial prostheses because the latter are stiffer, which
results in an increased transvalvular gradient, reduced cusp
mobility, and possible late thrombus formation (15). The
use of mechanical valves has decreased substantially in
patients with EA at our institution because of the increased risk
of thrombosis due to decreased RV function and low right
atrial and RV pressures, which results in abnormal prosthetic
disc motion, even in the presence of adequate warfarin antico-
agulation (15). Therefore, even in patients with EA with atrial
fibrillation, we have preferred bioprosthetic valve replacement.
We have not identified any late problems with the coronary
sinus draining into the RV. Questions may arise about the
potential detrimental effect on LV function because of in-
creased coronary sinus pressure when it drains into the RV.
Analysis of matched patients with EA in our practice, com-
Figure 2 Kaplan-Meier Survival Curve
Overall survival of study patients (n  81) versus expected survival (p  0.001).paring coronary sinus drainage into the right atrium versus the
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(Connolly HM, unpublished data).
Plication or resection of an atrialized RV is performed
only if it is thinned out and transparent. We do not believe
that this type of ventricular wall contributes to RV function
(3). In this series of older patients with EA, plication of the
atrialized RV was performed in only 13% of patients.
TV repair. Numerous TV repair techniques (14,16–18)
have been described; the most common types include cone
modification, Carpentier technique, and modifications of
the Danielson technique (17,19,20). Thirteen patients in
the current series had operations after the cone TV repair
modification was introduced at our center (January 2007);
TV replacement was performed in 11 of these patients, and
2 patients had TV repair, but the cone modification was not
used. Thus, we do not have experience with TV repair using
the cone technique in patients 50 years of age. We have
used the cone repair in approximately 85% of our younger
patients with EA, with a satisfactory repair in 90%.
Bidirectional cavopulmonary shunts have been de-
scribed as being helpful in patients with severe EA who
are at risk for right-sided heart failure (6). A bidirectional
cavopulmonary shunt was performed on only 2 patients in
our series, and neither patient had a single-ventricle
repair (RV exclusion) or needed cardiac transplant during
long-term follow-up.
Outcome in our patients was comparable to that in a large
series of 539 patients with EA from our center, in which
20-year survival was 71% (mean [range] age at surgery 24
years [8 days to 79 years]) and early mortality was 4.9% (3).
Thus, except in neonates with EA for whom early mortality
is increased (21,22), the outcome of EA surgery might be
age independent (23). Other centers have also reported
excellent outcomes in their patients with EA; however,
these series primarily involved younger patients (18).
Closure of any atrial septal communication. In most
patients with EA, an interatrial communication is present,
which is routinely closed during surgery. Some researchers
have suggested that isolated closure of an interatrial com-
munication in EA might cause right-sided heart failure.
ASD or patent foramen ovale closure was also performed in
10 of our patients before TV surgery, and right-sided heart
failure or sudden increase in TV regurgitation did not occur
in any of our patients.
Right-sided maze procedure. The incidence of atrial ar-
rhythmias increases with age in any patient, including those
with EA; thus, we believe that the maze procedure should
be applied liberally in patients with EA who require
operation. Although the presence of pre-excitation might
not affect outcome (3,4), the most current recommendation
is to proceed with arrhythmia intervention before or during
reparative surgery for EA (24). In the current era, we
generally perform a biatrial maze procedure when atrial
fibrillation is persistent. Overall, our approach is to address
all abnormalities at the time of operation (25). In this series,
we have no data on long-term success of arrhythmiaprocedures; however, success of these procedures in patients
with EA has been shown (24,26).
Study limitations. The excellent outcomes in this group of
patients with EA who are 50 years of age may be related
to a less severe anatomic variant. This certainly is true
compared with the defects in neonates; however, the same
selection criteria for surgery were applied in these patients as
in other adolescents or young adults with EA. There are no
data comparing surgical treatment with nonsurgical treat-
ment in these patients.
Cardiac magnetic resonance imaging was not used in this
group of patients but may provide additional future data about
the RV to risk-stratify patients for repair versus replacement.
Surgical techniques have evolved over the past 30 years in
an effort to decrease the number of valve replacements. This
has been largely successful in the pediatric and young adult
age groups, but further improvements in repair techniques
are necessary to ultimately decrease the number of TV
replacements in patients 50 years of age.
In this study, the number of patients with events was
small. Although some risk factors for mortality were iden-
tified, the low number of events resulted in limited study
power. This is reflected in wide confidence intervals on
estimated hazard ratios.
Conclusions
Cardiac surgery in patients with EA who are 50 years of
age may be complex; however, if the operations are per-
formed at a center with experience in congenital heart
disease, early mortality is low (4%) and long-term outcome
is excellent. Better survival is seen in patients with post-
operative improvement in functional class and in those who
are younger at the time of surgery. Cardiac surgery in EA at
an older age is feasible but palliative, and long-term
follow-up in these patients is required despite excellent
outcome. Our data showed that surgery should be per-
formed before EA disease is too advanced and patients are
too symptomatic.
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